This e-learning course discusses the therapeutic role of PARP inhibitors in prostate cancer.
Key topics include:

  • PARP inhibitor mechanism of action
  • Prevalence of DDR mutations in prostate cancer, and somatic and germline testing
  • Recent clinical trial data and ongoing studies
  • Efficacy and safety profiles of PARP inhibitors
  • Combination therapies and strategies for overcoming resistance

This course has been accredited by EACCME® for 1 ECMEC® (as detailed within the Introduction and Objectives below).